According to IMARC Group’s latest report, titled “Europe Medical Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The Europe medical cannabis market is expected to exhibit a CAGR of 22.8% during 2022-2027.
Medical cannabis is produced from the Cannabis plant to cure ailments, such as pain and mental and sleep disorders. It comprises active ingredients, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), which provide relief by healing the body from muscle, chronic, and nerve pain. It also assists in reducing anxiety, stress, and depression by restoring normal levels and functions of the brain chemicals. At present, there is a rise in the demand for medical cannabis across Europe to treat nausea and vomiting after chemotherapy.
Request Free Sample Report: https://www.imarcgroup.com/europe-medical-cannabis-market/requestsample
Market Trends
The legality of cannabis currently varies from one country to another across Europe. However, the gradually increasing legalization of medical cannabis for curing various illnesses represents one of the key factors driving the market in the region. For instance, it is utilized in treating cancer and neurological disorders, such as Alzheimer’s and Parkinson’s diseases, which is propelling the growth of the market. Moreover, the growing prevalence of chronic knee disorders due to osteoarthritis and meniscal injuries is positively influencing the market in the region. In addition, the rising awareness among the masses about the benefits of consuming medical cannabis is contributing to the growth of the market in Europe. Furthermore, key market players are extensively investing in research and development (R&D) activities to enhance the genetic improvement strategies for cannabis, which is bolstering the growth of the market.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=3059&flag=C
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
The report has segmented the market on the basis of species, derivative, application, end use, route of administration and country.
Breakup by Species:
- Indica
- Sativa
- Hybrid
Breakup by Derivative:
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Others
Breakup by Application:
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
Breakup by End Use:
- Pharmaceutical Industry
- Research and Development Centres
- Others
Breakup by Route of Administration:
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Related Reports By IMARC Group
Lead Acid Battery Market Report
Remote Patient Monitoring Market Research
Protein Supplements Market Growth
mRNA Vaccines and Therapeutics Market Trends
Flexible Packaging Market Growth
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800